References
- Ballester M, Dubernard G, Lécuru F, Heitz D, Mathevet P, Marret H, et al. 2011. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). The Lancet. Oncology 12:469–476.
- BGCS 2021. BGCS Uterine Cancer Guidelines: Recommendations for Practice; [cited 2022 April 23]. Available from: https://www.bgcs.org.uk/wp-content/uploads/2021/11/British-Gynaecological-Cancer-Society-v13-for-website-with-figure1.pdf.
- Cancer Research UK 2021. Uterine Cancer Statistics; [cited 2022 January 9]. Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer#heading-Zero.
- Erdemoglu E, Yalcin Y, Bozkurt KK, Erdemoglu E. 2017. Surgical staging of low-risk stage IA endometrioid endometrial cancers. European Journal of Gynaecological Oncology 38:80–84.
- Eriksson AGZ, Davidson B, Bjerre Trent P, Eyjólfsdóttir B, Dahl GF, Wang Y, Staff AC. 2021. Update on sentinel lymph node biopsy in surgical staging of endometrial carcinoma. Journal of Clinical Medicine 10:3094.
- Iyer R, Gentry-Maharaj A, Nordin A, Burnell M, Liston R, Manchanda R, et al. 2015. Predictors of complications in gynaecological oncological surgery: a prospective multicentre study (UKGOSOC-UK gynaecological oncology surgical outcomes and complications). British Journal of Cancer 112:475–484.
- Janda M, Armfield NR, Kerr G, Kurz S, Jackson G, Currie J, et al. 2020. Patient-reported experiences after hysterectomy: a cross-sectional study of the views of over 2300 women. Journal of Patient Experience 7:372–379.
- Kingston A, Robinson L, Booth H, Knapp M, Jagger C. 2018. Projections of multi-morbidity in the older population in England to 2035: estimates from the Population Ageing and Care Simulation (PACSim) model. Age and Ageing 47:374–380.
- Mueller JJ, Pedra Nobre S, Braxton K, Alektiar KM, Leitao MMJ, Aghajanian C, et al. 2020. Incidence of pelvic lymph node metastasis using modern FIGO staging and sentinel lymph node mapping with ultrastaging in surgically staged patients with endometrioid and serous endometrial carcinoma. Gynecologic Oncology 157:619–623.
- NCCN 2022. NCCN Guidelines: Uterine Neoplasms v1.2022. Available from: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473.
- NCIN 2019. National Cancer Intelligence Network. Overview of ovarian cancer in England: incidence, mortality and survival; [cited 2022 January 9]. Available from: https://www.cancerdata.nhs.uk/incidence_and_mortality.
- NCIN 2013. Uterine Cancer in the United Kingdom: overall trends and variation by age; [cited 2022 January 17]. Available from: http://www.ncin.org.uk/publications/data_briefings/uterine_cancer_in_the_united_kingdom_overall_trends_and_variation_by_age.
- Shoraka M, Wang S, Carbajal-Mamani SL, Han H, Amaro B, Cardenas-Goicoechea J. 2022. Oncologic outcomes in older women with endometrial carcinoma (≥70 years). Journal of Obstetrics and Gynaecology: The Journal of the Institute of Obstetrics and Gynaecology 1–7. https://doi.org/10.1080/01443615.2022.2033962.
- Togami S, Kubo R, Kawamura T, Yanazume S, Kamio M, Kobayashi H. 2020. Risk factors for lymphatic complications following lymphadenectomy in patients with endometrial cancer. Taiwanese Journal of Obstetrics & Gynecology 59:420–424.
- Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, 2nd, et al. 2006. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 106:812–819.
- Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, et al. 2014. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecologic Oncology 133:216–220.
- Volpi L, Sozzi G, Capozzi VA, Ricco’ M, Merisio C, Di Serio M, et al. 2019. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience. International Journal of Gynecologic Cancer 29:312–319.